FDA Safety Center Authority Would Extend To OTCs Under Grassley Bill

A new safety center proposed in Sen. Charles Grassley's "FDA Safety Act" (FDASA) would have broad postmarket authority over some over-the-counter drugs, as well as prescription pharmaceuticals and biologics